On February 26, 2024 Nusano, a physics company transforming the production of medical radioisotopes, reported it will participate in a presentation and panel at the B. Riley Securities Radiopharma Investor Conference in New York City on Friday, March 1, 2024 (Press release, Nusano, FEB 26, 2024, View Source [SID1234640458]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

—

What: Company Presentation
Who: Chris Lowe, Chief Executive Officer
When: 1:00 – 1:15 p.m. ET

—

What: Panel: Enough with Lu-177 and Ac-225? Other Isotopes in Store for Radiopharma
Who: Howard Lewin, Co-Founder and Chief Product Development Officer
When: 2:30 – 3:05 p.m. ET

—

Nusano management will also be available for 1-on-1 meetings with institutional investors. To request a meeting, qualified investors should contact [email protected] or their B. Riley Representative.